
Findings showed neutralizing antibody responses to BA.4 and BA.5 subvariants were approximately 20-fold lower than to the original WA1/2020 strain.

Findings showed neutralizing antibody responses to BA.4 and BA.5 subvariants were approximately 20-fold lower than to the original WA1/2020 strain.
Called SMART WARS, a new study assessed diagnostic utility of the 2 wearable devices in older adults and considered combined device/clinician interpretation of ECG readings.

Lyme disease is surrounded by its own cloud of misinformation. Here are 9 myths you might hear from patients this summer plus the facts-at-a-glance for backup.

When asthma and COPD patients have a continuous relationship with a single provider, ED visits/hospitalizations go down, survival goes up, finds a new systematic review.

Medicare Advantage plans may cut treatment corners to avoid more costly but more effective and targeted therapy for diabetes patients.

From type 2 diabetes to chronic yeast infection, we have picked the top 7 FDA-approved drugs every primary care physician should know about from the second quarter.

The FDA's move could potentially improve Paxlovid access for patients at high risk for severe COVID-19 who have limited access to health care.

Global life sciences company Labcorp began testing for monkeypox using the CDC’s orthopoxvirus test on Wednesday.

Less than 7% of the US population has "optimal" cardiometabolic health, with declines over 20 years significantly affecting racial/ethnic populations.

An analysis of US death certificate data found that COVID-19 was a top 5 cause of death in every age group aged 15 years and older.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.


Characteristics associated with discussions of wearable devices during primary care visits include female sex, higher income, and obesity, showed new study.
Drs Mikhail Kosiborod and Neil Skolnik discuss this unique moment in the history of T2D management that offers treatments to address its broad cardiometabolic impact.

In persons with COPD, seasonal influenza and PPSV23 vaccines, separately or together, reduced the risk for COPD- and pneumonia-related hospitalizations.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Suicidal ideation affects 1 in 15 physicians and job-related stress is often a reason for a suicide among them. A new study set out to find specifics.

The FDA recommended on Thursday the inclusion of a SARS-CoV-2 Omicron component in COVID-19 vaccine booster doses.

A new review summarized the current evidence about diagnosis and treatment of lumbar spinal stenosis. What are the key takeaways for primary care?

Authors of this first study to compare the combinations head-to-head suggest that the glycopyrrolate combination is appropriate for long-term COPD management.